Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE)
102.55
-4.01 (-3.76%)
Nov 12, 2026, 3:29 PM IST
NSE:LOTUSEYE Revenue
Lotus Eye Hospital and Institute had revenue of 179.71M INR in the quarter ending September 30, 2026, with 37.83% growth. This brings the company's total for the last twelve months to 619.40M, up 23.10% year-over-year. In the fiscal year ending March 31, 2026, Lotus Eye Hospital and Institute had annual revenue of 537.14M with 8.38% growth. That makes Lotus Eye Hospital and Institute the 39,341st largest company in the world by revenue and 3,690th in India.
Revenue (ttm)
619.40M
Revenue Growth
+23.10%
P/S Ratio
3.44
Revenue / Employee
1.54M
Employees
402
Market Cap
2.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 537.14M | 41.52M | 8.38% |
| Mar 31, 2025 | 495.63M | 13.53M | 2.81% |
| Mar 31, 2024 | 482.10M | 11.66M | 2.48% |
| Mar 31, 2023 | 470.44M | 81.34M | 20.90% |
| Mar 31, 2022 | 389.10M | 65.51M | 20.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shalby | 12.05B |
| GPT Healthcare | 5.10B |
| Max India | 2.84B |
| Unihealth Hospitals | 1.32B |
| Gujarat Kidney And Super Speciality | 1.27B |
| Vaidya Sane Ayurved Laboratories | 1.17B |
| Sangani Hospitals | 1.07B |
| Gaudium IVF and Women Health | 1.06B |